Brentuximab is used to treat certain types of cancers (Hodgkin's lymma, systemic anaplastic large lymma, periral T-lymma, primary cutaneous anaplastic large lymma, CD30-expressing mycosis fungoides). It works by slowing or stopping the growth of cancer .